INCY

SELL

Incyte Corporation

Healthcare · Rank #77 · Analyzed Jul 13, 2026

$116.71

Current Price

$65.65

Intrinsic Value

low confidence

Upside/Downside

4.5/10

Score

4.5/5

Quality

Analysis Summary

Valuation Consensus1/3 methods agree

Quality Score4.5/5.0

Framework RatingSELL

Price vs Intrinsic ValueLow confidence — see rating

Fair Value Range

Low$19.69

Base (IV)$65.65

High$173.71

Entry Points

Conservative$13.78

Moderate$19.69

Aggressive$45.95

⚠️ Warnings

DCF/EPV diverge 4.1x — earnings power and cash flow disagree; fair value is low-confidence (blended conservatively)

Quality & Moat Breakdown

Return on Equity30.8% → 1.0/1.0

Debt LevelD/E 1 → 1.0/1.0

Revenue QualityGrowth 19.2%, margin Δ+22.8% → 1.0/1.0

Moat Strength3.5/5 → 0.5/1.0

Profit Margins26.7% → 1.0/1.0

Methodology

This analysis uses a unified valuation framework combining three methods, Discounted Cash Flow (3-scenario), Earnings Power Value, and Asset Valuation, with a quality scoring overlay. A stock needs 2/3 valuation methods to agree and a quality score ≥ 3.5/5 for a BUY rating.

Learn how this framework works →

This is a personal analysis tool, not financial advice. Do your own research before making investment decisions.